Security key
90400D108
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 98,459,627
- Total 13F shares
- 95,480,928
- Share change
- +582,267
- Total reported value
- $2,872,333,685
- Put/Call ratio
- 48%
- Price per share
- $30.08
- Number of holders
- 301
- Value change
- -$30,390,841
- Number of buys
- 180
- Number of sells
- 147
Report period
Q3 2025
Institutions
301
Top holders
10
RARE full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Ultragenyx Pharmaceutical Inc. SEC filings
Ultragenyx Pharmaceutical Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90400D108
Recent filing periods:
Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.1%
from 13D/G
|
6,256,145
|
$227,473,430 | — | 30 Jun 2025 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13D/G
13F
|
Company |
4.7%
|
4,298,003
|
$163,238,154 | $0 | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
|
Company |
2.7%
|
2,457,543
|
$93,337,483 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
10,213,422
|
$371,360,023 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.3%
|
3,260,868
|
$118,565,172 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
2,886,268
|
$104,946,000 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.8%
|
2,772,692
|
$100,815,081 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
2.6%
|
2,604,588
|
$94,702,808 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
2,572,240
|
$93,526,646 | — | 30 Jun 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,278,000
|
$82,828,080 | — | 30 Jun 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.2%
|
2,140,577
|
$77,831,395 | — | 30 Jun 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.1%
|
2,049,501
|
$74,519,856 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,712,931
|
$62,291,362 | — | 30 Jun 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.7%
|
1,707,402
|
$62,081,137 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.7%
|
1,699,944
|
$61,909,359 | — | 30 Jun 2025 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.7%
|
1,685,729
|
$61,293,106 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.7%
|
1,665,852
|
$60,570,379 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.6%
|
1,529,474
|
$55,611,675 | — | 30 Jun 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.5%
|
1,452,130
|
$52,800,000 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.5%
|
1,429,437
|
$51,974,329 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.4%
|
1,391,072
|
$50,579,378 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
1.4%
|
1,350,000
|
$49,086,000 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.3%
|
1,255,203
|
$45,639,181 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.2%
|
1,163,755
|
$42,314,132 | — | 30 Jun 2025 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1%
|
983,715
|
$35,767,877 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
1%
|
983,638
|
$35,765,078 | — | 30 Jun 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.91%
|
898,000
|
$32,651,280 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.87%
|
860,400
|
$31,284,144 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.74%
|
724,115
|
$26,328,821 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.65%
|
638,879
|
$23,229,678 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.65%
|
637,690
|
$23,186,407 | — | 30 Jun 2025 | |
| Eagle Health Investments LP |
13F
|
Company |
0.64%
|
627,600
|
$22,819,536 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.63%
|
615,969
|
$22,396,633 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.62%
|
606,407
|
$22,048,959 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.59%
|
576,901
|
$20,976,120 | — | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.58%
|
567,175
|
$20,622,480 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.56%
|
551,383
|
$20,048,286 | — | 30 Jun 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.56%
|
549,538
|
$19,981,202 | — | 30 Jun 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.56%
|
547,905
|
$19,921,826 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.55%
|
540,801
|
$19,663,525 | — | 30 Jun 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.53%
|
526,267
|
$19,135,883 | — | 30 Jun 2025 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.53%
|
525,464
|
$19,105,871 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.52%
|
515,968
|
$18,760,596 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.51%
|
505,152
|
$18,367,326 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.51%
|
501,056
|
$18,218,396 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
493,470
|
$17,942,570 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.49%
|
486,632
|
$17,693,940 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
486,341
|
$17,683,359 | — | 30 Jun 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.49%
|
481,288
|
$17,500,000 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.48%
|
475,156
|
$17,276,672 | — | 30 Jun 2025 |
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q3 2025
As of 30 Sep 2025,
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by
301 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,480,928 shares.
The largest 10 holders included
VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., JPMORGAN CHASE & CO, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RTW INVESTMENTS, LP, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
302
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
307
Q3 2025 holders
301
Holder diff
-6
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.